InvestorsHub Logo

newman2021

08/05/22 8:21 AM

#501477 RE: alphapuppy #501473

thanks doctor alphapuppy for all you do here. I get it why we had 90% crossover. The patients thought the DcVaxL therapy does come with on top of the SOC which is by default the placebo therapy here. So, why not try something new while the SOC has limitations.

hoffmann6383

08/05/22 8:32 AM

#501483 RE: alphapuppy #501473

thanks for sharing alphapuppy

ilovetech

08/05/22 9:10 AM

#501495 RE: alphapuppy #501473

Photos of GBM patients who are dying daily should be blown up, and hand delivered to the faceless, accountable bureaucrats, who have failed to show any interest to follow through on their promises. Promises to usher in a new model for speedier lab to clinic treatments. I bet if DCVax was spelled DCPox, all hell would break loose in the halls and corridors of the agencies to get the untested, underpowered, zero long safety data vaccines to pregnant moms and new borns. What a Sh*t show. Oops, I must be a conspiracy theorist.

ILT

CrashOverride

08/05/22 9:11 AM

#501496 RE: alphapuppy #501473

Thank you Alphapuppy! Your KM charts were very useful in my due diligence process as it confirmed work performed by others and proved to be 100% accurate. The number of highly intelligent longs who own this stock must certainly be quite unrepresentative of the general investing public. I believe we will all be rewarded in due course. Let management execute their vision!

ATLnsider

08/05/22 10:07 AM

#501511 RE: alphapuppy #501473

Alphapuppy, thank you for sharing your thoughts doctor.

extrooper

08/05/22 10:19 AM

#501515 RE: alphapuppy #501473

quote “The only negative for me is I can’t offer it to patients now who are really in need. It’s sad to see them die from this disease without the opportunity of getting this new in exciting dendritic cell vaccine.”

Traders are more than willing to sacrifice patient’s health so they can make $ trading. The further wait is an example of the affects of government bureaucrats, paid off RAs around the world, shorts , pressure to keep small biotech from introducing better SOC by large pharma and the fact that share price reduces NWBO’s ability to monetize at a higher price, which would have reduced the amount of shares needed to pay the bills.

All making money off this stock are no better than any who profit off any tragedy.

JRROBYN

08/05/22 2:38 PM

#501640 RE: alphapuppy #501473

Why are YOU bringing up Enron?